Researchers identified a novel way to potentially slow or halt Alzheimer's progression by targeting the plexin-B1 protein. Their study shows how reactive astrocytes and plexin-B1 play crucial roles in clearing amyloid plaques. This discovery opens new pathways for Alzheimer's treatments and emphasizes the importance of cellular interactions.
